Supernus Pharmaceuticals's top three insider shareholders as of June 06, 2026 are Jack A. Khattar (President, Ceo, 2.20Mn shares), Charles W Iii Newhall (Director, 124.12K shares), John M Siebert (Director, 87.94K shares).
| Holder | Position | Shares (Direct) | Shares (Indirect) | Report Date |
|---|---|---|---|---|
| Charles W Iii Newhall | - | 124,119 | 0 | 25 Feb, 2026 |
| John M Siebert | - | 87,943 | 0 | 27 Feb, 2024 |
| Timothy C Dec | Senior Vice President Cfo | 8,232 | 0 | 10 Mar, 2026 |
| Georges Gemayel | - | 27,277 | 0 | 09 Mar, 2026 |
| Frederick M. Hudson | - | 60,413 | 0 | 16 Mar, 2026 |
| Padmanabh P. Bhatt | Sr. Vp Of Ip, Cso | 17,044 | 0 | 18 Mar, 2026 |
| Tami Tillotson Martin | Sr. V.P., Regulatory Affairs | 86,933 | 0 | 27 Feb, 2024 |
| Jack A. Khattar | President, Ceo | 1,241,144 | 958,100 | 16 Mar, 2026 |
| Carrolee Barlow | - | 27,045 | 0 | 25 Feb, 2026 |
| Frank Mottola | Svp, Chief Tech. Ops. Officer | 18,440 | 0 | 10 Mar, 2026 |
| Jonathan Rubin | Svp, Chief Medical Officer | 13,341 | 0 | 26 Feb, 2026 |
* Please note that the shares above only reflect shares from the fund portfolio and the institutional portfolio. Shares from the personal portfolio are excluded from this Institutional Ownership Page. See these insiders' latest transactions here on Insider Page.
| Transaction Date | Insider Name | Security Class | Transaction Type | Shares Traded | Price | Shares Remaining | Ownership | Code |
|---|---|---|---|---|---|---|---|---|
| 16 Mar, 2026 | Padmanabh P. Bhatt | Common Stock | A | 22,750 | $36.75 | 39,794 | D | M |
| 16 Mar, 2026 | Padmanabh P. Bhatt | Common Stock | A | 4,250 | $29.61 | 44,044 | D | M |
| 16 Mar, 2026 | Padmanabh P. Bhatt | Common Stock | A | 18,000 | $32.20 | 62,044 | D | M |
| 16 Mar, 2026 | Padmanabh P. Bhatt | Common Stock | A | 5,000 | $27.94 | 67,044 | D | M |
| 16 Mar, 2026 | Padmanabh P. Bhatt | Common Stock | D | 34,114 | $50.18 | 32,930 | D | S |
| 16 Mar, 2026 | Padmanabh P. Bhatt | Common Stock | D | 15,886 | $50.49 | 17,044 | D | S |
| 17 Mar, 2026 | Padmanabh P. Bhatt | Common Stock | A | 22,750 | $39.40 | 39,794 | D | M |
| 17 Mar, 2026 | Padmanabh P. Bhatt | Common Stock | A | 12,250 | $36.75 | 52,044 | D | M |
| 17 Mar, 2026 | Padmanabh P. Bhatt | Common Stock | A | 15,000 | $38.60 | 67,044 | D | M |
| 17 Mar, 2026 | Padmanabh P. Bhatt | Common Stock | D | 27,710 | $49.95 | 39,334 | D | S |
| 17 Mar, 2026 | Padmanabh P. Bhatt | Common Stock | D | 22,290 | $50.73 | 17,044 | D | S |
| 18 Mar, 2026 | Padmanabh P. Bhatt | Common Stock | A | 7,250 | $39.40 | 24,294 | D | M |
| 18 Mar, 2026 | Padmanabh P. Bhatt | Common Stock | D | 6,838 | $49.55 | 17,456 | D | S |
| 18 Mar, 2026 | Padmanabh P. Bhatt | Common Stock | D | 412 | $50.48 | 17,044 | D | S |
| 16 Mar, 2026 | Padmanabh P. Bhatt | Employee Stock Option (Right to Buy) | D | 22,750 | $0.00 | 12,250 | D | M |
| 16 Mar, 2026 | Padmanabh P. Bhatt | Employee Stock Option (Right to Buy) | D | 4,250 | $0.00 | 0 | D | M |
| 16 Mar, 2026 | Padmanabh P. Bhatt | Employee Stock Option (Right to Buy) | D | 18,000 | $0.00 | 0 | D | M |
| 16 Mar, 2026 | Padmanabh P. Bhatt | Employee Stock Option (Right to Buy) | D | 5,000 | $0.00 | 15,000 | D | M |
| 17 Mar, 2026 | Padmanabh P. Bhatt | Employee Stock Option (Right to Buy) | D | 22,750 | $0.00 | 7,250 | D | M |
| 17 Mar, 2026 | Padmanabh P. Bhatt | Employee Stock Option (Right to Buy) | D | 12,250 | $0.00 | 0 | D | M |